TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 14 | 28 | 32 | 8 | -12 | 93 | 27 |
| P | %wins | 100 | 100 | 100 | 100 | 0 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/17 20:26 | 8/14/17 | GSVC | Gsv Capital Corp. | Fund | CEF | Closed-End Funds | Mazur Marc | CA | D | P | 27 | 4.45 | 0 | 6 | New | 6 | D | ||||||||||||||||
6/6/14 09:20 | 6/4/14 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazur Marc | PA | D | P | 15 | 2.90 | 0 | 5 | New | 5 | D | -58 | -48 | -30 | -48 | -31 | -1 | 1 | -1 | 14 | 28 | 32 | 8 | -12 | 93 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |